Aditya Jandial, MD, DM
@Aditya_PGI
Followers
1K
Following
6K
Media
20
Statuses
698
Assistant Professor, Clinical Hematology @PGI_HematOnc, PGIMER Chandigarh | Banhore (Kathua, J&K)
Chandigarh, India
Joined January 2020
RT @Charanpreet_14: Excited to share our latest publication highlighting the use of a fixed, low dose of Nivolumab in patients with R/R Hod….
link.springer.com
Indian Journal of Hematology and Blood Transfusion - Several studies have explored different doses of checkpoint inhibitors in various malignancies, but the optimal dose remains undefined. Here, we...
0
5
0
RT @rudra09s025: 🧵5 Key Takeaways from Our Study on Composite MRD in Myeloma ASCT👇.📍Published in Blood Cell Therap….
0
8
0
RT @nihardesai89: 📢 Now out in @BrJHaem 🎊🎉. Our latest work from the @pmcancercentre explores how GvHD prophylaxis influences the risk of s….
0
16
0
RT @DrPMPGI: Glad to share a CML-focused podcast for South Asian patients, recorded for @MyCancerHaven — a platform dedicated to raising ca….
0
11
0
It was truly a great learning experience — a masterclass in every sense! @NitinJainMD .Grateful to have been part of it!.
👉Had a great time interacting with Hematology team at PGI Chandigarh.We had a marathon session of 6 hours! discussing CLL and ALL therapies, including patient case discussions .Many Thanks @DrPMPGI @ArihantDr @Charanpreet_14 and many others for active participation and
1
3
35
RT @cardio73: I randomly ask my patients about their profession—how they earn a living. Many share inspiring stories of struggle and resili….
0
1K
0
RT @rudra09s025: Comparable efficacy of venetoclax 50mg with posaconazole versus venetoclax 400mg in newly diagnosed AML patients: pharmaco….
ascopubs.org
6530Background: Metabolism of Venetoclax(VEN) by CYP3A enzymes gives a unique opportunity to administer it at a lower dose with a CYP3A inhibitor. Azoles are strong CYP3A inhibitors & they are...
0
17
0
RT @nihardesai89: @Haemophage has been so much more than a mentor, more like a (tor)mentor!. From medicine to life itself, he has taught me….
0
2
0
RT @DrGPrakash: Our Dept of Cl Hematology & Medical Oncology at #PGI organised an event with school and college students against tobacco. 🚭….
0
4
0
RT @rajenderpgimer: @Aditya_PGI @PGI_HematOnc @DrPMPGI @DrGPrakash Congratulations Dr Aditya .Welcome back to PGI.
0
3
0
RT @DrNikitaMehra: @Aditya_PGI @PGI_HematOnc @DrPMPGI @DrGPrakash @a_khadwal Congratulations, Dr. Aditya! Best wishes. Been looking forwar….
0
1
0
RT @nihardesai89: @Aditya_PGI @PGI_HematOnc @DrPMPGI @DrGPrakash @a_khadwal @Charanpreet_14 Congratulations 🎉👏🏽 Very well deserved 💪🏽.
0
1
0
Glad to share that I've joined my alma mater, PGIMER Chandigarh, as faculty in the Dept of Clinical Hematology and MedOnc @PGI_HematOnc . Always grateful to @DrPMPGI for his continued support and leadership. Looking forward to contributing to patient care, academics, and research
55
7
348
RT @Charanpreet_14: Delighted to share that ive joined the dept of clinical hematology & medical oncology at PGIMER, Chandigarh as Assistan….
0
4
0
RT @lingarajnayak: A LMIC perspective on managing adverse events in haematological malignancy. Privileged to lead this @TheLancet paper w….
thelancet.com
Haematological malignancies encompass a heterogeneous group of life-threatening disorders, including leukaemias, lymphomas, and myelomas, which need intricate and frequently intensive therapeutic...
0
19
0
A heartfelt goodbye to Tata Memorial Centre, Punjab @HBCHRC_Punjab, where I had the privilege to serve as faculty for almost 2 years. I am grateful for the learning, friendships, and unwavering support. @docgulia.@seemagulia1.@HemeDoc_Pooja
6
0
56
RT @MichaelMindrum: I have zero respect for a researcher, perched in an ivory tower publishing thousands of papers, who publicly tells a p….
0
522
0
RT @HBCHRC_Punjab: In observance of Multiple Myeloma Awareness Month, the Department of Medical Social Services, in partnership with the Ad….
0
5
0
RT @rudra09s025: Grateful for the opportunity to share my work, connect with experts, and learn from inspiring discussions. Thank you @Ind….
0
5
0